pamidronate has been researched along with Primary Myelofibrosis in 4 studies
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some patients with primary hypertrophic osteoarthropathy display an interesting palindrome." | 2.44 | Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation. ( Martinez-Lavin, M; Rivera-Viñas, M; Vargas, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haidar, JH | 1 |
| Bazarbachi, A | 1 |
| Nasr, MR | 1 |
| El-Sabban, ME | 1 |
| Daher, R | 1 |
| Perkins, P | 1 |
| Curtin, NJ | 1 |
| Green, AR | 1 |
| Booth, S | 1 |
| Assous, N | 1 |
| Foltz, V | 1 |
| Fautrel, B | 1 |
| Rozenberg, S | 1 |
| Etchepare, F | 1 |
| Bourgeois, P | 1 |
| Martinez-Lavin, M | 1 |
| Vargas, A | 1 |
| Rivera-Viñas, M | 1 |
1 review available for pamidronate and Primary Myelofibrosis
| Article | Year |
|---|---|
Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation.
Topics: Bone Density Conservation Agents; Crohn Disease; Diphosphonates; Ductus Arteriosus, Patent; Humans; | 2008 |
3 other studies available for pamidronate and Primary Myelofibrosis
| Article | Year |
|---|---|
Signet ring-like light chain myeloma with systemic spread.
Topics: Anemia; Antineoplastic Agents; Bone Marrow Examination; Combined Modality Therapy; Diagnostic Errors | 2003 |
Pain from myelofibrosis treated with regular pamidronate.
Topics: Adult; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diphosphonates; Dru | 2004 |
Bone involvement in myelofibrosis: effectiveness of bisphosphonates.
Topics: Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Middle Aged; Osteo | 2005 |